Lauren Richardson

Lauren Richardson currently serves as the Executive Director of Regulatory Affairs at Fulcrum Therapeutics, a position held since May 2023. Prior to this role, Lauren held various leadership positions at PhaseBio Pharmaceuticals, Inc. from February 2010 to July 2023, including VP of Regulatory and Quality, where responsibilities included the development of regulatory and quality systems and management of regulatory interactions throughout clinical stages. Lauren's career also includes significant roles at NuPathe Inc., BioRexis Pharmaceuticals Corporation, Merck, and Ives Envision, with a progressive expertise in regulatory affairs and quality assurance. Lauren holds a Master of Science in Quality Assurance and Regulatory Affairs from Temple University School of Pharmacy and a Bachelor of Science in Biology/Microbiology from Commonwealth University-Bloomsburg.